Eurofins to Establish New Facility in Scotland
Eurofins Scientific (Luxembourg), an international group of laboratories, has plans to establish a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland.
Eurofins Livingston facility
Eurofins Scientific (Luxembourg), an international group of laboratories, has plans to establish a new pharmaceutical chemistry and microbiology facility in Livingston, Scotland, as part of a £4 million investment.
The 5800-square meter facility at Brucefield Industry Park will house Eurofin’s biopharmaceutical testing business in the UK, currently based in Edinburgh. The first phase of the project will include the development of 1400 square meters of laboratory space.
As part of the investment, Eurofins BioPharma Product Testing UK will be purchasing a new inductively coupled plasma-mass spectrometry (ICP-MS) instrument, allowing the company to meet growing demand for this service as a result of new International Conference Harmonization (ICH) guidelines and pharmacopeial chapters on testing drugs for elemental impurities. Eurofins will also invest in more high-performance liquid chromatography (HPLC) equipment, increasing that capacity by 40%.
Newsletter
Get essential updates on the latest spectroscopy technologies, regulatory standards, and best practices—subscribe today to Spectroscopy.
AI-Powered Raman with CARS Offers Laser Imaging for Rapid Cervical Cancer Diagnosis
July 15th 2025Chinese researchers have developed a cutting-edge cervical cancer diagnostic model that combines spontaneous Raman spectroscopy, CARS imaging, and artificial intelligence to achieve 100% accuracy in distinguishing healthy and cancerous tissue.
How Analytical Chemists Are Navigating DOGE-Driven Funding Cuts
July 14th 2025DOGE-related federal funding cuts have sharply reduced salaries, lab budgets, and graduate support in academia. Researchers view the politically driven shifts in priorities as part of recurring systemic issues in U.S. science funding during administrative transitions. The impact on Federal laboratories has varied, with some seeing immediate effects and others experiencing more gradual effects. In general, there is rising uncertainty over future appropriations. Sustainable recovery may require structural reforms, leaner administration, and stronger industry-academia collaboration. New commentary underscores similar challenges, noting scaled-back graduate admissions, spending freezes, and a pervasive sense of overwhelming stress among faculty, students, and staff. This article addresses these issues for the analytical chemistry community.
